Literature DB >> 3206110

Comparison of the tyrosine kinase activity with the proliferation rate in human colon solid tumors and tumor cell lines.

G Kéri1, A Balogh, I Teplán, O Csuka.   

Abstract

The role of the tyrosine kinase signal transduction pathway was investigated in human colon solid tumors and colon tumor cell lines. A high level of tyrosine kinase activity was found in 7 of the 27 human solid tumors tested (26%). In these cases, a close correlation between the level of tyrosine kinase activity and the high ratio of the S phase cells has been demonstrated (r = 0.8418). High autophosphorylation accompanied by a high proliferation capacity was detected in 8 cases (29.6%). In 12 cases (44%) low tyrosine kinase activity with a lower proliferation rate was found. Seven of the 8 human colon tumor cell lines tested showed tyrosine kinase activity. Differentiation-inducing agents, such as sodium butyrate and retinoic acid, have been applied to influence the rate of cell proliferation. Treatment with 5 mM sodium butyrate (24 h) and 10 microM retinoic acid (48 h) effectively decreased the fraction of S phase cells and 3H-thymidine incorporation. The tyrosine kinase activity fell to 9-22% and to 44-65% of the original value in the case of the sodium butyrate and retinoic acid treatment, respectively. Our results suggest that a significant part of human colon tumors have an active tyrosine kinase signal transduction pathway and that tyrosine kinase plays a role in the process of proliferation rather than in the process of differentiation in these human colon tumor cell lines.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3206110     DOI: 10.1159/000217578

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  3 in total

1.  A tumor-selective somatostatin analog (TT-232) with strong in vitro and in vivo antitumor activity.

Authors:  G Kéri; J Erchegyi; A Horváth; I Mezõ; M Idei; T Vántus; A Balogh; Z Vadász; G Bökönyi; J Seprõdi; I Teplán; O Csuka; M Tejeda; D Gaál; Z Szegedi; B Szende; C Roze; H Kalthoff; A Ullrich
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-29       Impact factor: 11.205

2.  Tumor cells express FcgammaRI which contributes to tumor cell growth and a metastatic phenotype.

Authors:  M B Nelson; J K Nyhus; K I Oravecz-Wilson; E Barbera-Guillem
Journal:  Neoplasia       Date:  2001 Mar-Apr       Impact factor: 5.715

Review 3.  Retinoic Acids in the Treatment of Most Lethal Solid Cancers.

Authors:  Lara Costantini; Romina Molinari; Barbara Farinon; Nicolò Merendino
Journal:  J Clin Med       Date:  2020-01-28       Impact factor: 4.241

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.